Genome sequence of an industrial microorganism <i>Streptomyces avermitilis</i> : Deducing the ability of producing secondary metabolites
-
- Satoshi Ōmura
- The Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8642, Japan; School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan; National Institute of Infectious Diseases, Tokyo 162-8640, Japan; and National Institute of Technology and Evaluation, Tokyo 151-0066, Japan; School of Sciences, Kitasato University, Kanagawa 228-8555, Japan; Institute of Medical Science, University of Tokyo, 4-6-1, Shiokane-dai, Minato-ku, Tokyo 108-8639, Japan; and The Institute of...
-
- Haruo Ikeda
- The Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8642, Japan; School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan; National Institute of Infectious Diseases, Tokyo 162-8640, Japan; and National Institute of Technology and Evaluation, Tokyo 151-0066, Japan; School of Sciences, Kitasato University, Kanagawa 228-8555, Japan; Institute of Medical Science, University of Tokyo, 4-6-1, Shiokane-dai, Minato-ku, Tokyo 108-8639, Japan; and The Institute of...
-
- Jun Ishikawa
- The Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8642, Japan; School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan; National Institute of Infectious Diseases, Tokyo 162-8640, Japan; and National Institute of Technology and Evaluation, Tokyo 151-0066, Japan; School of Sciences, Kitasato University, Kanagawa 228-8555, Japan; Institute of Medical Science, University of Tokyo, 4-6-1, Shiokane-dai, Minato-ku, Tokyo 108-8639, Japan; and The Institute of...
-
- Akiharu Hanamoto
- The Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8642, Japan; School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan; National Institute of Infectious Diseases, Tokyo 162-8640, Japan; and National Institute of Technology and Evaluation, Tokyo 151-0066, Japan; School of Sciences, Kitasato University, Kanagawa 228-8555, Japan; Institute of Medical Science, University of Tokyo, 4-6-1, Shiokane-dai, Minato-ku, Tokyo 108-8639, Japan; and The Institute of...
-
- Chigusa Takahashi
- The Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8642, Japan; School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan; National Institute of Infectious Diseases, Tokyo 162-8640, Japan; and National Institute of Technology and Evaluation, Tokyo 151-0066, Japan; School of Sciences, Kitasato University, Kanagawa 228-8555, Japan; Institute of Medical Science, University of Tokyo, 4-6-1, Shiokane-dai, Minato-ku, Tokyo 108-8639, Japan; and The Institute of...
-
- Mayumi Shinose
- The Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8642, Japan; School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan; National Institute of Infectious Diseases, Tokyo 162-8640, Japan; and National Institute of Technology and Evaluation, Tokyo 151-0066, Japan; School of Sciences, Kitasato University, Kanagawa 228-8555, Japan; Institute of Medical Science, University of Tokyo, 4-6-1, Shiokane-dai, Minato-ku, Tokyo 108-8639, Japan; and The Institute of...
-
- Yoko Takahashi
- The Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8642, Japan; School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan; National Institute of Infectious Diseases, Tokyo 162-8640, Japan; and National Institute of Technology and Evaluation, Tokyo 151-0066, Japan; School of Sciences, Kitasato University, Kanagawa 228-8555, Japan; Institute of Medical Science, University of Tokyo, 4-6-1, Shiokane-dai, Minato-ku, Tokyo 108-8639, Japan; and The Institute of...
-
- Hiroshi Horikawa
- The Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8642, Japan; School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan; National Institute of Infectious Diseases, Tokyo 162-8640, Japan; and National Institute of Technology and Evaluation, Tokyo 151-0066, Japan; School of Sciences, Kitasato University, Kanagawa 228-8555, Japan; Institute of Medical Science, University of Tokyo, 4-6-1, Shiokane-dai, Minato-ku, Tokyo 108-8639, Japan; and The Institute of...
-
- Hidekazu Nakazawa
- The Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8642, Japan; School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan; National Institute of Infectious Diseases, Tokyo 162-8640, Japan; and National Institute of Technology and Evaluation, Tokyo 151-0066, Japan; School of Sciences, Kitasato University, Kanagawa 228-8555, Japan; Institute of Medical Science, University of Tokyo, 4-6-1, Shiokane-dai, Minato-ku, Tokyo 108-8639, Japan; and The Institute of...
-
- Tomomi Osonoe
- The Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8642, Japan; School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan; National Institute of Infectious Diseases, Tokyo 162-8640, Japan; and National Institute of Technology and Evaluation, Tokyo 151-0066, Japan; School of Sciences, Kitasato University, Kanagawa 228-8555, Japan; Institute of Medical Science, University of Tokyo, 4-6-1, Shiokane-dai, Minato-ku, Tokyo 108-8639, Japan; and The Institute of...
-
- Hisashi Kikuchi
- The Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8642, Japan; School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan; National Institute of Infectious Diseases, Tokyo 162-8640, Japan; and National Institute of Technology and Evaluation, Tokyo 151-0066, Japan; School of Sciences, Kitasato University, Kanagawa 228-8555, Japan; Institute of Medical Science, University of Tokyo, 4-6-1, Shiokane-dai, Minato-ku, Tokyo 108-8639, Japan; and The Institute of...
-
- Tadayoshi Shiba
- The Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8642, Japan; School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan; National Institute of Infectious Diseases, Tokyo 162-8640, Japan; and National Institute of Technology and Evaluation, Tokyo 151-0066, Japan; School of Sciences, Kitasato University, Kanagawa 228-8555, Japan; Institute of Medical Science, University of Tokyo, 4-6-1, Shiokane-dai, Minato-ku, Tokyo 108-8639, Japan; and The Institute of...
-
- Yoshiyuki Sakaki
- The Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8642, Japan; School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan; National Institute of Infectious Diseases, Tokyo 162-8640, Japan; and National Institute of Technology and Evaluation, Tokyo 151-0066, Japan; School of Sciences, Kitasato University, Kanagawa 228-8555, Japan; Institute of Medical Science, University of Tokyo, 4-6-1, Shiokane-dai, Minato-ku, Tokyo 108-8639, Japan; and The Institute of...
-
- Masahira Hattori
- The Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8642, Japan; School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan; National Institute of Infectious Diseases, Tokyo 162-8640, Japan; and National Institute of Technology and Evaluation, Tokyo 151-0066, Japan; School of Sciences, Kitasato University, Kanagawa 228-8555, Japan; Institute of Medical Science, University of Tokyo, 4-6-1, Shiokane-dai, Minato-ku, Tokyo 108-8639, Japan; and The Institute of...
書誌事項
- タイトル別名
-
- Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolites.
抄録
<jats:p> <jats:italic>Streptomyces avermitilis</jats:italic> is a soil bacterium that carries out not only a complex morphological differentiation but also the production of secondary metabolites, one of which, avermectin, is commercially important in human and veterinary medicine. The major interest in this genus <jats:italic>Streptomyces</jats:italic> is the diversity of its production of secondary metabolites as an industrial microorganism. A major factor in its prominence as a producer of the variety of secondary metabolites is its possession of several metabolic pathways for biosynthesis. Here we report sequence analysis of <jats:italic>S. avermitilis</jats:italic> , covering 99% of its genome. At least 8.7 million base pairs exist in the linear chromosome; this is the largest bacterial genome sequence, and it provides insights into the intrinsic diversity of the production of the secondary metabolites of <jats:italic>Streptomyces</jats:italic> . Twenty-five kinds of secondary metabolite gene clusters were found in the genome of <jats:italic>S. avermitilis</jats:italic> . Four of them are concerned with the biosyntheses of melanin pigments, in which two clusters encode tyrosinase and its cofactor, another two encode an ochronotic pigment derived from homogentiginic acid, and another polyketide-derived melanin. The gene clusters for carotenoid and siderophore biosyntheses are composed of seven and five genes, respectively. There are eight kinds of gene clusters for type-I polyketide compound biosyntheses, and two clusters are involved in the biosyntheses of type-II polyketide-derived compounds. Furthermore, a polyketide synthase that resembles phloroglucinol synthase was detected. Eight clusters are involved in the biosyntheses of peptide compounds that are synthesized by nonribosomal peptide synthetases. These secondary metabolite clusters are widely located in the genome but half of them are near both ends of the genome. The total length of these clusters occupies about 6.4% of the genome. </jats:p>
収録刊行物
-
- Proceedings of the National Academy of Sciences
-
Proceedings of the National Academy of Sciences 98 (21), 12215-12220, 2001-09-25
Proceedings of the National Academy of Sciences
関連研究データ
もっと見る- Tweet
キーワード
詳細情報
-
- CRID
- 1364233268386292352
-
- NII論文ID
- 80012875477
-
- ISSN
- 10916490
- 00278424
-
- PubMed
- 11572948
-
- データソース種別
-
- Crossref
- PubMed
- CiNii Articles
- Integbio